Credit Suisse’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,163
| Closed | -$164K | – | 3103 |
|
|
2023
Q3 | $164K | Sell |
5,163
-776
| -13% | -$24.6K | ﹤0.01% | 3049 |
|
|
2023
Q2 | $488K | Buy |
5,939
+1,784
| +43% | +$147K | ﹤0.01% | 2778 |
|
|
2023
Q1 | $427K | Buy |
4,155
+256
| +7% | +$26.3K | ﹤0.01% | 2813 |
|
|
2022
Q4 | $571K | Sell |
3,899
-208
| -5% | -$30.5K | ﹤0.01% | 2684 |
|
|
2022
Q3 | $693K | Buy |
4,107
+885
| +27% | +$149K | ﹤0.01% | 2567 |
|
|
2022
Q2 | $373K | Buy |
3,222
+184
| +6% | +$21.3K | ﹤0.01% | 3018 |
|
|
2022
Q1 | $304K | Buy |
3,038
+369
| +14% | +$36.9K | ﹤0.01% | 3201 |
|
|
2021
Q4 | $415K | Buy |
2,669
+585
| +28% | +$91K | ﹤0.01% | 3146 |
|
|
2021
Q3 | $492K | Sell |
2,084
-82
| -4% | -$19.4K | ﹤0.01% | 2997 |
|
|
2021
Q2 | $736K | Buy |
2,166
+28
| +1% | +$9.51K | ﹤0.01% | 2812 |
|
|
2021
Q1 | $863K | Sell |
2,138
-2,392
| -53% | -$966K | ﹤0.01% | 2661 |
|
|
2020
Q4 | $3.01M | Buy |
4,530
+20
| +0.4% | +$13.3K | ﹤0.01% | 1874 |
|
|
2020
Q3 | $2.1M | Buy |
4,510
+2,199
| +95% | +$1.02M | ﹤0.01% | 1779 |
|
|
2020
Q2 | $1.35M | Buy |
+2,311
| New | +$1.35M | ﹤0.01% | 2132 |
|
|
2019
Q4 | – | Sell |
-435
| Closed | -$17K | – | 3539 |
|
|
2019
Q3 | $17K | Buy |
+435
| New | +$17K | ﹤0.01% | 3414 |
|